Terlipressin safe and effective use recommendations to reduce risks of respiratory failure and septic shock in patients with type 1 hepatorenal syndrome
MHRA released a drug safety update to disseminate recommendations for safe and effective use of terlipressin. Terlipressin is a synthetic pituitary hormone, an analog of the vasoconstrictor vasopressin which acts by reducing portal venous pressure in the liver, in patients with portal hypertension, and also contributes to improved blood circulation in the kidney helping to…